Okada S, York D A, Bray G A, Erlanson-Albertsson C
Pennington Biomedical Research Center, Baton Rouge, LA 70808.
Physiol Behav. 1991 Jun;49(6):1185-9. doi: 10.1016/0031-9384(91)90349-s.
Valine-proline-aspartate-proline-arginine (VPDPR), the amino terminal pentapeptide of pancreatic procolipase, produced a dose-dependent reduction in food intake when injected intraperitoneally into Osborne-Mendel rats that had been starved overnight. This inhibition of feeding was observed when the rats were fed a high-fat diet but not in rats fed a high-carbohydrate, low-fat diet. At higher doses of VPDPR, the inhibition of feeding was maintained for over 6 hours. An equimolar mixture of the free amino acids had no effect on food intake. In rats adapted to a three-choice macronutrient diet, VPDPR inhibited fat intake but had no effect on carbohydrate or protein intake. This selective inhibition of fat intake was observed in both overnight-fasted rats presented with food and in ad-lib-fed rats at the beginning of the dark-onset feeding period. It is suggested that this peptide may be a feedback signal to regulate the intake of dietary fat.
缬氨酸 - 脯氨酸 - 天冬氨酸 - 脯氨酸 - 精氨酸(VPDPR),即胰腺前脂酶的氨基末端五肽,当腹腔注射到禁食过夜的奥斯本 - 孟德尔大鼠体内时,会使食物摄入量呈剂量依赖性减少。当给大鼠喂食高脂饮食时可观察到这种摄食抑制现象,而在喂食高碳水化合物、低脂饮食的大鼠中则未观察到。在较高剂量的VPDPR作用下,摄食抑制可维持6小时以上。游离氨基酸的等摩尔混合物对食物摄入量没有影响。在适应三种宏量营养素饮食选择的大鼠中,VPDPR抑制脂肪摄入,但对碳水化合物或蛋白质摄入没有影响。在给禁食过夜的大鼠提供食物时以及在黑暗开始进食期开始时自由采食的大鼠中,均观察到这种对脂肪摄入的选择性抑制。提示该肽可能是调节膳食脂肪摄入的一种反馈信号。